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ABSTRACT 
THE ROLE OF CYTOPROTECTIVE AND NON-PROTECTIVE AUTOPHAGY IN 
RADIATION SENSITIVITY IN BREAST TUMOR CELLS 
Le, J; Nakajima, W; Harada, H; and Gewirtz, D. 
 
A thesis in partial fulfillment of the requirements for the degree of 
Master of Science in Pharmacology and Toxicology at  
Virginia Commonwealth University, 2014 
 
By Jade Ngoc Le 
 
Major Director: David Gewirtz 
Professor, Department of Pharmacology and Toxicology 
Richmond, Virginia 
 
In general, ionizing radiation promotes cytoprotective autophagy in a majority of 
breast tumor cells. Previous studies from our laboratory indicated that radiation (5x2 
x"
"
Gy) induces cytoprotective autophagy in MCF-7 cells. In the current work, inhibition of 
autophagy by silencing of Beclin-1 in MCF-7 cells resulted in an increase in sensitivity 
to radiation based both on cell number and clonogenic survival; however, there was 
no increase in apoptosis and the basis for this sensitization is currently under 
investigation. Unexpectedly, enhancement of autophagy by silencing of Bcl-2 also led 
to an increase in sensitivity to radiation, possibly through the conversion of 
cytoprotective to cytostatic autophagy. In contrast to the MCF-7 cells, radiation (5x2 
Gy) induces non-protective autophagy in Hs578t cells. Interference with autophagy 
through silencing of Beclin-1 or induction of Bcl-2 did not alter radiation sensitivity in 
the Hs578t cells. Since the induction of cytoprotective autophagy can represent an 
impediment to radiation therapy, it is important to understand the types of autophagy 
that occur in response to radiation in specific cellular settings and whether 
interference with autophagy can increase sensitivity to different forms of cancer 
treatment. 
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CHAPTER 1: INTRODUCTION 
1.1 Cancer 
Cancer is a major public health problem in the United States and other countries 
around the world. According to Siegel et al. (Siegel et al., 2013), one in four 
deaths in the United States are due to cancer. Cancer can be understood as a 
disease of malfunctioning cells that keep growing and accumulating. It is the 
general name for a group of more than 100 diseases, and can be grouped into 
five categories: 
Carcinoma: cancer that arises from epithelial tissues that line the walls of 
cavities or in the case of skin covering the outside of the body and is responsible 
for more than 80% of the cancer-related death in the Western world. There are 
two main types of carcinoma that include squamous cell carcinomas—tumors 
that arise from epithelial cells that line and protect the underlying cells, and 
adenocarcinomas—tumors that arise from specialized epithelial cells that 
secrete substances into the ducts or cavities that they line (Weinberg, R., 2007).  
Sarcoma: cancer that begins in bone, cartilage, fat, muscles, blood vessels, or 
other connective or supportive tissues (www.cancer.gov). The sarcomas 
constitute about 1% of the tumors encountered in the oncology clinic (Weinberg, 
R., 2007).   
Leukemia: cancer arises from cell lineages that constitute the blood-forming 
tissues and move freely through the circulation.  
Lymphomas:  cancer begins in the cells of the immune system that aggregate to 
form solid tumors. 
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Central nervous system cancer: cancers arise from cells that form the central 
and peripheral nervous system.  
1.2 Breast Cancer 
Breast cancer is the second leading cause of cancer death in women in the 
United States (Jemal et al., 2011). According to the U.S. Breast Cancer 
Statistics 2013, about one in eight women in the U.S. will develop invasive 
breast cancer over the course of her life (www.breastcancer.org). Breast cancer 
can be divided into 2 large groups based on specific molecular markers 
including hormone-receptor [HR; estrogen receptor (ER) and progesterone 
receptor (PR)]-positive and HR-negative negative breast cancers. The HR-
positive breast cancer can be sub-divided into two groups defined as luminal A 
and B tumors depending on the expression level of human epidermal growth 
factor receptor 2 (HER2). The HR-negative breast cancer can be sub-divided 
into two groups determined by HER2 expression including HER2-
overexpressing tumors and HER2-negative tumors (Rakha et al., 2008). 
About 65-70% of invasive breast cancers are HR-positive tumors, called luminal 
tumors, whose cells express high level of estrogen-hormone receptors and/or 
progesterone-hormone receptors and associated genes (Schnitt, 2010). The 
luminal type of breast cancer tends to exhibit a good prognosis since they are 
estrogen receptor-positive (ER+) and/or progesterone receptor-positive (PR+). 
The luminal A subtype is characterized by lacking the human epidermal growth 
factor receptor 2 (HER2-) which distinguishes it from the luminal B subtype. The 
first line clinical treatment of luminal type of breast cancer is endocrine therapy, 
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through targeting of hormone functions (tamoxifen to inhibit ER function) or 
blocking their synthesis (aromatase inhibitor to block estrogen synthesis). 
Usually, luminal A subtype exhibits better clinical outcomes in response to 
endocrine therapy than luminal B subtypes. Since 30% of ER+ breast cancers 
were reported resistant to hormonal therapy, additional therapeutic strategies 
are required for optimal outcomes (Zhang et al., 2014).  
About 15% of invasive breast cancers are characterized by HER2 
overexpression. HER2 overexpression in breast tumors is often associated with 
low expression of ER and associated genes (Schnitt, 2010).  HER2- human 
epidermal growth factor 2- belongs to a family of receptors including 
EGFR/HER1, HER2, HER3, and HER4 and functions by stimulating the 
signaling pathway of growth factors (Gajria and Chandarlapaty, 2011). Over-
expression of HER2 leads to the continued activation of growth signaling 
pathway and contributes to the growth of breast cancer cells. HER2-positive 
breast cancer tends to be aggressive, fast growing, and less responsive to 
hormonal therapy. However, treatments for HER2-positive breast cancer have 
been shown to be very effective when pharmacologically targeting at HER2. The 
most common pharmacologic treatment used is trastuzumab (Herceptin), a 
monoclonal antibody that binds to the extracellular domain of HER2 receptors, 
blocking cancer cells but not normal cells from receiving growth signals. The use 
of trastuzumab in combination with chemotherapy shows effectiveness in the 
case of advanced-stage breast cancer and reduces the risk of disease 
recurrence (Gajria and Chandarlapaty, 2011). 
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Another group belonging to the HR-negative subtype is triple negative (TN) 
breast cancer, which constitutes about 12-24% of breast cancer (Sorlie et al., 
2001; Bertucci et al., 2000; Bertucci et al., 2004). TN breast cancer is defined as 
HR negative/PR negative/HER2 negative, and does not benefit from some of the 
most effective therapies against breast cancer such as hormonal therapy or 
HER2 targeting therapy (Rakha et al., 2008). TN breast cancer is associated with 
a worse prognosis, has a high rate of recurrence, and causes majority of death 
within the first 3 to 5 years after initial treatment (Ovcaricek et al., 2011). 
Chemotherapy is usually the only therapeutic option to treat TN breast cancer 
because of their lack of hormonal receptors and HER2. Anthracycline and 
anthracycline/taxane treatment usually results in good initial effects in treating of 
TN breast tumors, but they also yield a rapid relapse rate. Currently, there are 
several emerging agents under clinical trials for treatment of TN breast cancer 
such as platinum agent, poly (ADP-ribose) polymerase (PARP) inhibitors which 
interfere with DNA repair and are hoped to improve prognosis for patients with 
TN breast cancer (Ovcaricek et al., 2011).  
1.3. Autophagy 
Autophagy is a self-eating process by which cytoplasmic materials are delivered 
to and degraded in the lysosome (Mizushima and Komatsu, 2011). There are 
three major types of autophagy depending on the route by which the cytoplasmic 
materials delivered to the lysosome: chaperone-mediated autophagy (CMA), 
microautophagy, and macroautophagy (Klionsky, 2005). In CMA, unfolded, 
soluble proteins are directly translocated across the lysosomal membrane 
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without involvement of membrane formation. In microautophagy, cytoplasmic 
materials are directly engulfed into the lysosome by inward invagination of the 
lysosomal membrane (Mizushima and Komatsu, 2011). Macroautophagy 
(hereafter referred to as autophagy), which is thought to be the major type of 
autophagy, involves the intermediate formation of autophagosomes, which 
sequester cytoplasmic materials, and finally fuse with the lysosome to degrade 
the components. 
Autophagy is a dynamic and multi-step process. The Atg1/ULK1 complex is an 
essential initiator of autophagy, which is normally remained inactivated by 
binding with mammalian Target of rapamycin (mTORC1), a master regulator of 
nutrient signaling. Under stressful conditions such as nutrition starvation, 
mTORC1 dissociates from the Atg1/ULK1 complex, and allows the complex to 
phosphorylate downstream Atg proteins for autophagosome formation 
(Mizushima, 2010). The autophagosome is a double-membrane organelle that is 
derived from endoplasmic reticulum, Golgi apparatus, and/or mitochondria 
organelles. The autophagosome formation process consists of four major steps 
including isolation membrane formation, nucleation, elongation, and completion 
steps. Initially, the class III phosphoinositide 3-kinase (PI3K or Vps34) is 
associated with Beclin-1 (Atg6) and p150 to form the class III PI3K core complex. 
The complex triggers vesicle nucleation, which sequesters the cytoplasmic 
component into an isolation membrane called the phagophore. Next, complete 
sequestration and phagophore elongation are supported by two ubiquitin-like 
protein conjugation systems Atg12-Atg5 complex and LC3 (Atg8). The Atg12-
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Atg5 complex consists of Atg12, Atg5, and Atg16L and plays role in recruiting 
additional membrane to complete the autophagosomes membrane formation. 
Then, lipidated LC3-II (a PE conjugated form of LC3 after the protein is cleaved 
by Atg4) associates with the newly formed autophagosomes to become the inner 
composition of autophagosomal membrane. Next, autophagosomes fuses with 
lysosomes, forming the autophagolysosome, to complete the autophagy 
pathway. This degradative process of autophagy is selective and mediated 
through p62/sequestosome 1 (SQSTM1), a mammalian protein that binds to LC3 
(Bjorkoy et al., 2005; He and Klionsky, 2009). Finally, the inner membrane of the 
autophagosomes and the ubiquinated cargo are degraded by lysosomal 
hydrolase to complete the autophagic degradation (Pyo et al., 2012).  
Autophagy is an important catabolic mechanism that occurs in cancer (Ouyang et 
al., 2012). The functions of autophagy in tumor cells are controversial and 
remained to be elucidated. In general, autophagy is well known for its 
cytoprotective function to maintain the cell homeostasis during period of 
starvation or stresses (He and Klionsky, 2009; Ouyyang et al., 2012). It is also 
well established that autophagy can induce cell death independently of other 
types of programmed cell deaths such as apoptosis when coping with excessive 
stress (Bialik et al., 2010; Eisenberg-Lerner et al., 2009; Ouyang et al., 2012). 
Recently, it has been proposed that at least two more functions of autophagy 
may occur in response to stresses, including non-protective and cytostatic 
functions (Gewirtz, 2014). Thus, it is challenging but critical to analyze which 
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function autophagy plays in cancer cells in response to stressful conditions such 
as radiation and chemotherapy treatments. 
 
Figure 1.1. Various steps involved in autophagy (Denton et al., 2012). 
1.4  Apoptosis 
Apoptosis, or type I programmed cell death (PCD), is a major cell death modality 
to control cell proliferation or in response to DNA damage (Ghobrial et al., 2005). 
Apoptosis is characterized by nuclear condensation and fragmentation, cell 
shrinkage, dynamic membrane blebbing, and loss of adhesion to the 
surroundings (Nishida et al., 2008; Ouyang et al., 2012) Apoptosis can occur 
through two main pathways: the extrinsic or cytoplasmic pathway, and the 
intrinsic or mitochondrial pathway. The two pathways will finally converge to the 
activation of a cascade of caspase proteases for execution of the apoptosis 
process (Ghobrial et al., 2005).  
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The extrinsic apoptotic pathway is triggered when extracellular ligand Fas-L 
binds to Fas plasma membrane death receptor (or other similar receptors). The 
Fas complex then recruits Fas-associated death domain protein (FADD) and pro-
caspase-8 to activate caspase-8, which in turn proceeds to activate the rest of 
the downstream caspases (Wajant, 2002). 
The intrinsic apoptotic pathway is involved in the activation and translocation of 
proapoptotic proteins to the mitochondria. The BCL-2 (B cell lymphoma gene-2) 
family proteins are key regulators of the intrinsic apoptotic pathway and can be 
classified into pro-apoptotic and anti-apoptotic functions (Weinberg, 2007). The 
pro-apoptotic proteins are divided into two groups: the BH-3 only proteins (Bad, 
Bid, Bim, Bmf, Bik, Hrk, Noxa, and Puma) and the multidomain proteins (Bax, 
Bak, and Bok).  The anti-apoptotic proteins include Bcl-2, Bcl-xL, Bcl-w, and Mcl-
1 which antagonize Bax/Bak under normal conditions. In response to intrinsic 
apoptotic stimuli, the BH-3 only proteins are activated and subsequently block 
the Bcl-2 proteins anti-apoptotic function. Thus, Bax/Bak are activated and 
mediated the release cytochrome c from the mitochondria into the cytosol. 
Cytochrome c then recruits Apaf-1 and pro-caspase-9, leading to the activation of 
caspase-9, which in turn activates the rest of the downstream signaling cascade 
and leads to apoptosis (Ghobrial et al., 2005).   
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Figure 1.2. Schematic extrinsic and intrinsic pathways of apoptosis (Youle and 
Strasser, 2008). 
1.5  Bcl-2:Beclin-1 interaction regulates autophagy 
Beclin-1 is a key regulator of autophagy in mammalian cells (Liang et al., 1999; 
Cao and Klionsky, 2007). Beclin-1 recruits key autophagic proteins to promote 
formation of a complex of Beclin 1, Vps34, and Vps15 which is important to 
initiate the autophagosome formation and induce autophagy (He and Levine, 
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2010). Recently, Beclin-1 was classified as a BH-3 only protein, which binds to 
the anti-apoptotic Bcl-2 proteins (Oberstein et al., 2007). The Beclin-1/Bcl-2 
interaction functions as a key regulatory mechanism in Beclin-1-dependent 
autophagy (Decuypere et al., 2012).  In normal conditions, Bcl-2 binds to Beclin-1 
and inhibits its autophagy function. When the cells are under stressful conditions, 
Beclin-1 dissociates from Bcl-2 and associates with Vps34, allowing subsequent 
activation of autophagy (Decuypere et al., 2012).  It is also important to mention 
that not mitochondrial but only ER-localized Bcl-2 is able to regulate Beclin-1-
dependent autophagy (Pattingre et al., 2005).  
 
Figure 1.3. Bcl-2 as an anti-apoptosis and anti-autophagy protein (Marquez and 
Xu, 2012). 
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1.6  Previous studies 
Previously our lab has demonstrated that MCF-7 breast cancer cells when 
irradiated with fractionated doses of 5x2 Gy induced cytoprotective autophagy 
which prevented radiation-induced cell death. However, when radiation was used 
in combination with EB1089, an analog of Vitamin D, cytoprotective autophagy 
was converted into cytotoxic form, which was associated with a reduction in the 
number of viable cells (Wilson et al., 2011; Bristol et al., 2012). Thereby, 
cytotoxic and cytoprotective functions of autophagy can occur in the same 
experimental system, which can be exploited to enhance the effects of cancer 
therapies. In addition, data from our lab (Chakradeo et al., manuscript in 
preparation) have demonstrated that fractionated doses of 5x2 Gy did not induce 
cytoprotective autophagy in Hs578t breast cancer cells. Instead, the autophagy 
induced in Hs578t when being blocked with autophagy inhibitors 3-
methyladenine (3-MA) and Chloroquine (CQ) did not sensitize the cells to 
radiation treatment. Thereby, our lab has termed it non-protective autophagy. 
Furthermore, recent studies from our lab also demonstrated that another function 
of autophagy, termed cytostatic autophagy, could be induced and resulted in 
cellular growth arrest. Thus, we suggested that multiple functions of autophagy 
can occur between different cells lines and/or conversion can happen within one 
cellular system. Since autophagy can be a mode of cellular resistance to 
treatment, interference of autophagy, therefore, can increase sensitivity to 
treatment and can become therapeutic benefits to cancer therapy. 
1.7 Hypothesis 
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Numerous studies have suggested that autophagy can function as either 
cytoprotective (pro-survival) or cytotoxic (pro-death) functions (Levine and Yuan, 
2005; Eskelinen, 2005; Zong and Thompson, 2006; Nelson and White, 2004). In 
addition, studies from our lab have indicated that using the same radiation 
treatment condition (5 x 2Gy) resulted in the induction of cytoprotective 
autophagy in MCF-7 cells (Wilson et al., 2011; Bristol et al., 2012) and non-
protective autophagy in Hs578t (manuscript in preparation). Here, I hypothesize 
that enhancement of radiation-induced autophagy in MCF-7 cells leads to a 
decrease in sensitivity to radiation. In contrast, interference in radiation-induced 
autophagy in Hs578t does not alter sensitivity to radiation. 
CHAPTER 2: MATERIALS AND METHODS 
2.1 Cell lines and cell culture. 
MCF-7 and Hs578t mammalian breast tumor cell lines were purchased from the 
American Type Culture Collection (ATCC). 293T cells were kindly provided by 
Dr. Hisashi Harada (Virginia Commonwealth University, VA, USA). MCF-7/shBcl-
2, MCF-7/shBeclin-1, Hs578t/Bcl-2, and Hs578t/shBeclin-1 cells were maintained 
using (1ug/ml) puromycin (Sigma p8833) for selection. All the cells were cultured 
in DMEM supplemented with 10% heat-activated fetal bovine serum (FBS) and 
5% of 100ug/ml penicillin G/streptomycin and maintained at 37oC in a humidified, 
5% CO2 incubator. 
2.2 Plasmid construction and virus infection. 
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The lentiviral shRNA constructs to target Bcl-2 and Beclin-1 were kindly provided 
by Dr. Hisashi Harada (Virginia Commonwealth University, VA, USA). To 
generate recombinant lentivirus, the 293T cells (1 x 106 cells total) were plated on 
a 10mm cell culture dish. Transfection steps were carried out 2 days later as the 
293T became approximately 70% confluence. First, 5µg of the shRNA constructs 
(including 2.5µg of interested shRNA and 2.5µg of lentiviral packaging plamids) 
were mixed into 200µL of RPMI medium (Gibco). In a separate tube, 15µL of 
Lipofectamine 2000 reagent (Invitrogen) was diluted into another 200µL of RPMI 
medium. Next, the diluted Lipofectamine reagent was added drop wise into the 
DNA solution while gently vortexing the DNA-containing tube. The mixture was 
incubated for 15-20 minutes at room temperature. Finally, the DNA-
Lipofectamine mixture was added gently into the 293T cells. The medium was 
replaced after 14-18 hours overnight. After two days of incubation, the lentivirus 
shed into the medium was collected and used to infect the breast tumor cells of 
interest.  
The retrovirus pBabe-puro Bcl-2 expressing vector was kindly provided by Dr. 
Wataru Nakajima (Nippon Medical School, Kawasaki, Japan). The vector was 
transfected into 293T cells along with the retrovirus packaging plasmids. The 
retrovirus shed into the medium was collected and used to infect Hs578t cells.  
2.3 Cell viability and clonogenic survival. 
Cell viability was determined by Trypan blue exclusion assay at different time 
points after treatment. The cells were seeded in triplicate in twelve well tissue 
14""
culture dishes with a concentration of 0.5 x 105 cells per well in 1ml medium. The 
cells were trypsinized and collected together with the supernatant, centrifuged at 
4000 x g for 5 minutes, and washed twice with PBS. The viability was determined 
using 0.4% Trypan Blue dye (Sigma T8154), and counted using phase contrast 
microscopy. For clonogenic survival studies, treated cells were plated in six well 
tissue culture dishes with a concentration of 1 x 104 cells per well in 2ml medium. 
After 12 days, the cells were fixed with 100% methanol, air-dried, and stained 
with 0.1% crystal violet (Sigma C3886). Number of counted colonies was 
normalized relative to untreated controls, which were taken as 100% survival. 
2.4 Detection and quantification of autophagic cells. 
Acridine orange allows the visualization of an autophagy marker, which is the 
cellular acidic compartment. Cells were plated in triplicate in six well tissue 
culture dishes and treated as described above for the cell viability study. After 
treatment fort appropriate times, the cells were incubated with medium containing 
1µg/ml acridine orange (Invitrogen A3568) for 10 minutes. The medium 
containing acridine orange was removed, and the cells were washed once with 
PBS. Fresh PBS was added, and images were taken using an Olympus inverted 
fluorescence microscope. All images were taken under 20x magnifications. Flow 
cytometry was used to quantify for the number of cells with acidic vesicular 
organelles (AVO). The cells were treated in the same manner and analyzed by 
BD FACSCanto II using FCS Express 4 Flow Research Edition software. A 
minimum of 10000 cells within the gated region was analyzed. 
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2.5 Immunoprecipitation and Western blot analyses. 
For immunoprecipitation, cells were lysed in CHAPS lysis buffer (20mM Tris (pH 
7.4), 137 mM NaCl, 1 mM dithiothreitol (DTT), and 1% CHAPS (3-[(3-
cholamidopropyl) dimethylammonio]-1-propanesulfonate) containing 1:50 
protease inhibitor and 1:100 phosphatase inhibitors in M-PER mammalian 
protein extraction reagent (Thermo Scientific). 500 µg of protein were captured 
with protein G Sepharose beads (Pharmacia LKB, Biotechnology AB, Uppsala, 
Sweden) and incubated with Beclin-1 antibody (Cell Signaling) at 4oC for 2 hours. 
After 3 times washing with the same CHAPS lysis buffer, the beads were re-
suspended in sample buffer and separated by SDS-PAGE. For Western blotting 
analyses, cells were lysed with lysis buffer containing 1:50 protease inhibitor and 
1:100 phosphatase inhibitor in M-PER mammalian protein extraction reagent 
(Thermo Scientific). Equal amounts of proteins were loaded on a SDS acrylamide 
gel, transferred onto a PVDF membrane using transfer buffer (700ml DI water, 
200ml methanol, and 100ml 10X Tris/Glycine). The membrane was blocked for 
30 minutes using blotto mixture (5% skim milk in 0.1% Tween-20 of 1 x PBS). 
After blocking, the membrane was incubated with respective antibodies 
overnight. After three times washing with TPBS (0.1% Tween-20 of 1 x PBS), the 
membrane was incubated with appropriate secondary antibodies followed by 
three times washing with TPBS. The membrane was developed using Pierce 
ECL Plus Western Blotting Substrate (Thermo Sciencetific #32132). Protein 
concentrations were determined using Bradford method. Primary antibodies used 
were cleaved PARP (Cell Signaling), p62 (BD Transduction), Beclin-1(Cell 
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Signaling), Mcl-1 (Enzo), Bcl-xL (Cell Signaling), Bcl-2 (Sigma), LC3 (Cell 
Signaling). All primary antibodies presented were used at a 1:1000 dilution. 
2.6 Statistical analysis. 
Values represent the means +/- SE for three separate experiments. The 
significance of differences between the experimental variables was analyzed 
using a one-way ANOVA followed by Bonferroni post-hoc test. Values with 
P<0.05 were considered as statistically different. 
CHAPTER 3: RESULTS 
Section 1: Radiation induced cytoprotective autophagy in MCF-7 cell. 
3.1.1 Silencing of Beclin-1 inhibited autophagy and increased sensitivity in 
MCF-7 cell in response to radiation. 
In MCF-7, ionizing radiation at 5x2 Gy promoted cytoprotective autophagy. 
Pharmacological inhibition of autophagy using 3-methyladenine (10mM) and 
chloroquine (25µM) resulted in growth inhibition or cell death (Wilson et al., 2011; 
Bristol et al., 2012). To further confirm previous results, I generated a stable 
MCF-7 cell line that expressed Beclin-1 short-hairpin RNA (shRNA). Figure 
3.1.1a shows that Beclin-1 expression was successfully suppressed in MCF-7 
cell. Acridine orange staining was utilized to monitor the induction of autophagy 
(which stains the late state of autophagosomes after fusion with lysosomes, 
indicated as acidic vesicular organelles). Figure 3.1.1b indicates that radiation 
alone induced autophagic vesicle formation in MCF-7/control cell. Silencing of 
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Beclin-1 reduced the increased level of autophagic vesicles caused by radiation. 
In Figure 3.1.1c, quantification of acidic vesicular organelles indicates that 
radiation-induced autophagy was statistically significant within 0 hour post 
radiation. Silencing of Beclin-1 could suppress or at least did not promote the 
formation of acidic vesicular organelles. To further assess whether silencing of 
Beclin-1 could inhibit the completion of autophagy, or autophagic flux, I 
performed Western blot analysis to examine the degradation of p62 protein. The 
protein p62, also mentioned as sequestosome 1 (SQSTM1), is an LC3-II binding 
protein whose degradation is indicative of autophagic flux. In Figure 3.1.1d, down 
regulation of p62 was observed at 24 hours post radiation in MCF-7. On the other 
hand, p62 level remained unchanged at 0 hour and 24 hours post radiation in 
MCF-7/shBeclin-1 as compared to the NT (none treatment) cells. Thus silencing 
of Beclin-1 could inhibit autophagy induced by radiation in MCF-7 cells.  
Next, Trypan blue exclusion assay was performed to determine the number of 
viable cells after Beclin-1 silencing. In Figure 3.1.1e, radiation alone could induce 
about 50% of growth inhibition at 0 hour post radiation and 60% at 24 hours in 
MCF-7/control cell.  When radiation was performed in combination with Beclin-1 
silencing, the growth inhibition effects were increased to 80% at 0 hour and 70% 
at 24 hours post radiation. Percentage of cell viability was determined utilizing 
the same Trypan blue exclusion assay, where the number of viable cells was 
normalized to the total number of viable and dead cells. In Figure 3.1.1f, the 
percentage of viable cells were almost 97%, indicating minimum cell death 
occurred within 24 hours post treatment. 
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To further confirm the increase in growth inhibition after Beclin-1 silencing, I 
performed clonogenic survival assay to measure the ability of colony formation in 
MCF-7 after Beclin-1 silencing. A clonogenic survival assay is often used to 
measure the efficacy of a treatment by observing the ability of a single cell to 
form a colony. In Figure 3.1.1g, radiation alone could inhibit about 30% the ability 
of colony formation. However, when radiation was combined with Beclin-1 
silencing, the inhibition effect was increased to about 50%. Thus, silencing of 
Beclin-1 could inhibit autophagy and significantly suppress the colony formation 
in the radiated MCF-7 cells. The data suggested that radiation-induced 
autophagy in MCF-7 performed cytoprotective function. 
  
19""
a. 
 
 
  
b. 
   
 
  
 
 
 
 
 
 
Figure 3.1.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in MCF-
7 cell. (a) Western blot analyses of endogenous Beclin-1 in MCF-7 cells infected 
with control or Beclin-1 shRNA. β-actin was used as a loading control. (b) 
Acridine orange images were taken at 24 hours post radiation using an inverted 
fluorescent microscope. NT: no treatment. IR: radiation. 
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Figure 3.1.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in MCF-
7 cell. (c) Acridine orange staining of acidic vesicles quantified by flow cytometry. 
Measurement of autophagy induction based on % acidic vesicle formation was 
monitored by acridine orange staining and quantified by flow cytometry within 0 
hour and 24 hours post radiation. *, p < 0.05; **, p < 0.01; ***, p < 0.001. One-
way ANOVA was followed by Bonferroni post-hoc test. Results were taken from 
three independent experiments. (d) Cell lysates were collected at NT, 0 hour, and 
24 hours post radiation and subjected to Western blot analyses with the indicated 
antibodies. β-actin was used as a loading control. NT: no treatment. IR: radiation. 
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Figure 3.1.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in MCF-
7 cell. (e) MCF-7 cells were plated with a concentration of 5x104 cells per well 
(six well tissue culture dish). The cells were exposed to radiation (5x2 Gy) over a 
period of 3 days. Number of viable cells was determined by Trypan Blue 
exclusion assays at NT, 0 hour and 24 hours post radiation. (f) Percentage of cell 
viability was determined by Trypan blue exclusion assay. The viable cell number 
was normalized to the total number of viable cells and dead cells. (g) After 
exposure to radiation, the cells were immediately plated with a concentration of 
1x104 cells per well (six well tissue culture dish). Number of colonies was 
determined by clonogenic survival assays over a period of 12 days. *, p < 0.05; 
**, p < 0.01; ***, p < 0.001. One-way ANOVA was followed by Bonferroni post-
hoc test. Results were taken from three independent experiments.
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3.1.2 The interaction between Beclin-1 and the anti-apoptotic Bcl-2 proteins 
in MCF-7 cells 
In order to enhance the level of radiation-induced autophagy in MCF-7 cell, I 
generated a MCF-7/shBcl-2 cell and examine the interaction between Bcl-2 
family proteins and Beclin-1. In Figure 3.1.2a, silencing of Bcl-2 in MCF-7 was 
demonstrated by Western blot analyses. The levels of Bcl-xL, Mcl-1 and Beclin-1 
remained unchanged after Bcl-2 was silenced as compared to the control cells. 
Next, co-immunoprecipitation assay was performed to determine the ability of 
Bcl-2 family proteins to interact with Beclin-1. In Figure 3.1.2b, the interaction of 
Beclin-1 to Bcl-xL or Mcl-1 was very weak or undetectable, respectively. 
However, endogenous Bcl-2 in MCF-7 clearly bound to Beclin-1, indicating that 
interfering with Bcl-2/Beclin-1 interaction could alter the level of radiation-induced 
autophagy in MCF-7 cell. 
  
24""
a. b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.2 Endogenous Bcl-2 interacts with Beclin-1 in MCF-7 cells. (a) 
Western blots analyses for the silencing of Bcl-2. MCF-7 cells were infected with 
lentivirus-encoding shRNA for non-targeting control or Bcl-2. GAPDH was used 
as a loading control (b) Immunoprecipitation (IP) with Beclin-1. Total cell lysates 
were subjected to IP with anti-Beclin-1. Western blot analyses were carried out 
on the precipitated samples with the indicated antibodies. 
 
25""
3.1.3 Silencing of Bcl-2 enhanced the level of radiation-induced autophagy 
in MCF-7 cell. 
To examine whether silencing of Bcl-2 could interfere with the level of autophagy 
induced by radiation in MCF-7 cell, I assessed the formation of acidic vesicular 
organelles by acridine orange and quantified by flow cytometry.  
Figure 3.1.3a demonstrates the Bcl-2 level after the introduction of Bcl-2 shRNA 
into MCF-7 cell. In Figure 3.2.3b, acridine orange images indicate that radiation 
alone induced autophagic vesicle formation in MCF-7 cell. Silencing of Bcl-2 
further increased the formation of the autophagic vesicles caused by radiation. In 
Figure 3.1.3c, quantification of acidic vesicular organelles indicate that in MCF-7 
cell the percentage of acidic vesicles came from 3.7% in no treatment condition 
to 10.5% at 0 hour and 18.8% at 24 hours post radiation. On the other hand, in 
MCF-7/shBcl-2 the percentage of acidic vesicles from 6.6% in no treatment 
condition was brought up to 21.6% at 0 hour and to 26.2% at 24 hours by 
radiation.  
In addition to the acridine orange results indicating the enhancement of 
autophagy by Bcl-2 silencing, Western blot analyses in Figure 3.1.3d show that 
LC3-II accumulation was much higher in MCF-7/shBcl-2 cell as compared to 
MCF-7 cell, indicating higher level of autophagic vesicle formation. Furthermore, 
p62 degradation was observed earlier in MCF-7/shBcl-2 cell (started at 6 hour 
post radiation) as compared to MCF-7 cell (started at 24 hour post radiation).  
In short, the data in Figure 3.1.3 suggest that silencing of Bcl-2 could enhance 
the level of radiation-induced autophagy in MCF-7 cell.  
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Figure 3.1.3 Silencing of Bcl-2 enhanced the level of radiation-induced 
autophagy in MCF-7 cell. (a) Bcl-2 level was analyzed using Western blotting in 
the control and Bcl-2 shRNAs transfected vectors. (b) Acridine orange images 
were taken 24 hours post radiation using an inverted fluorescent microscope. 
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Figure 3.1.3 Silencing of Bcl-2 enhanced the level of radiation-induced 
autophagy in MCF-7 cell. (c) Measurement of autophagy induction based on % 
acidic vesicle formation was monitored by acridine orange staining and quantified 
by flow cytometry within 0 hour and 24 hours post radiation. *, p < 0.05; **, p < 
0.01; ***, p < 0.001. One-way ANOVA was followed by Bonferroni post-hoc test. 
Results were taken from three independent experiments. (d) MCF-7 cells were 
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exposed to radiation (5x2 Gy) over a period of 3 days. Cell lysates were collected 
at 0, 6, 12, and 24 hours post radiation and subjected to Western blot analyses 
with the indicated antibodies. β-actin was used as a loading control.   
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3.1.4 Enhancement of autophagy by Bcl-2 silencing increased growth 
inhibition effects produced by radiation in MCF-7 cell. 
Trypan blue exclusion assays were performed to determine the number of viable 
cells after exposure to radiation. In Figure 3.1.4a, radiation alone could 
significantly inhibit cell growth in MCF-7/control cell at 0 hour and 24 hours post 
radiation. The growth inhibition effects of radiation were further increased in 
MCF-7/shBcl-2, in contrast with the hypothesis that enhancement of autophagy 
would further protect the cells from radiation. In Figure 3.1.4b, percentage cell 
viability was determined by normalizing the number of viable cells to the total 
number of viable cells and dead cells after 0 hour and 24 hours post radiation, 
indicating that minimum cell death was observed. Furthermore, Western blot 
analysis suggests that no cleaved-PARP expression was observed in either 
MCF-7/control or MCF-7/shBcl-2 cells, indicating minimum apoptosis happened 
within 24 hours post radiation (Figure 3.1.4c). In addition, data in Figure 3.1.4d 
taken from clonogenic survival assay indicates that radiation in combination with 
Bcl-2 silencing could significantly increase the inhibition effects on colony 
formation in MCF-7 cells as compared to radiation alone. In short, data in Figure 
3.1.4 suggests that enhancement of autophagy through Bcl-2 silencing increased 
the growth inhibition effects produced by radiation. 
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Figure 3.1.4 Enhancement of autophagy through Bcl-2 silencing increased the 
growth inhibition effects produced by radiation. MCF-7 cells were exposed to 
radiation (5x2 Gy) over a period of 3 days. (a) Number of viable cells was 
determined by Trypan blue exclusion assays in NT cells, and at 0 hour and 24 
hours post radiation. (b) Number of viable cells was normalized to the total 
number of viable and dead cells to calculate for the percentage of viable cells.   
31""
c. 
 
d. 
 
 
 
 
 
""""""
Figure 3.1.4 Enhancement of autophagy through Bcl-2 silencing increased the 
growth inhibition effects produced by radiation. (c) Cell lysates were collected 
and Western blot analyses were performed with the indicated antibodies.  (d) 
Number of colonies was determined by clonogenic survival assays over a period 
of 12 days. *, p < 0.05; **, p < 0.01; ***, p < 0.001. One-way ANOVA was 
followed by Bonferroni post-hoc test. Results were taken from three independent 
experiments. 
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Section 2: Radiation induced non-protective autophagy in Hs578t cell. 
3.2.1 Silencing of Beclin-1 inhibited radiation-induced autophagy and 
minimum changes in radiation sensitivity were observed. 
Recent studies from our lab have proposed that 5x2 Gy radiation could induce 
non-protective autophagy in Hs578t cells. Pharmacological interference of 
autophagy using 3-methyladenine (10 mM) and chloroquine (25 uM) did not 
result in growth inhibition or cell death. To confirm these previous data, 
Hs578t/shBeclin-1 cells were generated. Figure 3.2.1a shows that Beclin-1 
expression was suppressed in Hs578t. Cells were stained with acridine orange 
and subsequent quantification of acidic vesicular organelles was followed. In 
Figure 3.2.1b acridine orange images indicate that radiation alone strongly 
induced autophagic vesicle formation in Hs578t cell. The level of acridine orange 
staining was significantly attenuated after Beclin-1 was silenced. Figure 3.2.1c 
indicates that radiation alone could bring the autophagic vesicle level from 8.1% 
in NT condition to 40.4% at 0 hour post radiation. Silencing of Beclin-1 
expression could suppress about 25% of the autophagic vesicle level, indicating 
that autophagy induction was successfully inhibited. To examine whether Beclin-
1 silencing could inhibit autophagic flux, I performed Western blot to analyze p62 
degradation. In Figure 3.2.1d, degradation of p62 started as early as 0 hour post 
radiation and continued to be clearly degraded at 24 hours post radiation in 
Hs578t cells. On the other hand, p62 level remained unchanged in 
Hs578t/shBeclin-1 cells. Thus, silencing of Beclin-1 could inhibit autophagy 
induction and completion in Hs578t cells. 
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Next, in order to determine the growth ability of the cells after interference with 
autophagy through Beclin-1 silencing, I performed Trypan blue exclusion assay, 
counting for the number of viable cells. Figure 3.2.1e indicates that no significant 
differences in growth inhibition effects between radiation alone and radiation in 
combination with Beclin-1 silencing were detected. Percentage of cell viability 
calculated in Figure 3.2.1f suggests that minimum cell death happened within 24 
hours post radiation. Furthermore, clonogenic survival assay indicates that 
radiation alone could suppress about 20% of colony formation in Hs578t. 
Moreover, inhibition of autophagy by silencing of Beclin-1 did not alter the colony 
formation in the presence of radiation (Figure 3.2.1g), in agreement with our 
previous data (manuscript in preparation). In other words, inhibition of autophagy 
through Beclin-1 silencing did not change the sensitivity of Hs578t cells to 
radiation. 
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Figure 3.2.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in 
Hs578t cell. (a) Western blot analyses of endogenous Beclin-1 in Hs578t cells 
transfected with control or Beclin-1 shRNAs lentivirus constructs. α–tubulin was 
used as a loading control. (b) Acridine orange images were taken at 24 hours 
post radiation using an inverted fluorescent microscope.
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Figure 3.2.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in 
Hs578t cell. (c) Acridine orange staining of acidic vesicles quantified by flow 
cytometry. Measurement of autophagy induction based on % acidic vesicle 
formation was monitored by acridine orange staining and quantified by flow 
cytometry within 0 hour and 24 hours post radiation. *, p < 0.05; **, p < 0.01; ***, 
p < 0.001. One-way ANOVA was followed by Bonferroni post-hoc test. Results 
were taken from three independent experiments. (d) Cell lysates were collected 
in NT cells, and 0 hour and 24 hours post radiation. The lysates were subjected 
to Western blot analyses with the indicated antibodies. β-actin was used as a 
loading control. 
36""
"
 
e. 
 
 
 
 
 
 
 
 
 
 
 
 
f. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
g.  
37""
"
Figure 3.2.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in 
Hs578t cell. (e) Hs578t cells were plated with a concentration of 5x104 cells per 
well (six well tissue culture dish). The cells were exposed to radiation (5x2 Gy) 
over a period of 3 days. Number of viable cells was determined by Trypan Blue 
exclusion assays in NT cells, and 0 hour and 24 hours post radiation. (f) 
Percentage of cell viability was determined by Trypan blue exclusion assay. The 
viable cell number was normalized to the total number of viable cells and dead 
cells. (g) After exposure to radiation, the cells were immediately plated with a 
concentration of 1x104 cells per well (six well tissue culture dish). Number of 
colonies was determined by clonogenic survival assays over a period of 12 days. 
*, p < 0.05; **, p < 0.01; ***, p < 0.001. One-way ANOVA was followed by 
Bonferroni post-hoc test. Results were taken from three independent 
experiments.
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3.2.2 The expression levels of autophagy-related proteins in MCF-7 and 
Hs578t cells 
To identify factors that could be responsible for the induction of different types of 
autophagy, I determined the expression levels of autophagy related proteins in 
MCF-7 and Hs578t cells. Western blot analyses in Figure 3.2.2 indicates that 
Atg-5, a critical regulator of autophagy, was similarly expressed in the two cell 
lines. On the other hand, the expression of Beclin-1, an essential initiator of 
autophagy, was much higher in Hs578t as compared to MCF-7 cells. Since 
Beclin-1 has been shown to interact with the anti-apoptotic Bcl-2 proteins, and 
the interaction inhibits Beclin-1 autophagic function (Liang et al., 1998), it is 
important to determine the expression levels of the anti-apoptotic Bcl-2 proteins. 
The Western blot indicates that Bcl-xL and Mcl-1 were similarly expressed in 
MCF-7 and Hs578t cells. Surprisingly, while MCF-7 expressed high level of Bcl-
2, Bcl-2 expression was undetectable in Hs578t. 
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Figure 3.2.2 Western blot analyses demonstrated the expression levels of 
autophagy-related proteins in MCF-7 and Hs578t cells. Equal amounts of protein 
lysates were subjected to Western blot analyses using the indicated antibodies.   
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3.2.3 The interaction between Beclin-1 and the exogenous Bcl-2 in Hs578t 
cell. 
In Figure 3.2.3a, Bcl-2 retrovirus construct was introduced into Hs5787t cells and 
the expression was demonstrated by Western blot analyses. The levels of Bcl-xL, 
Mcl-1 and Beclin-1 remained unchanged after Bcl-2 introduction as compared to 
the control cells. To examine the interaction between Beclin-1 and Bcl-2 proteins 
in Hs578t cells, I performed co-immunoprecipitation as demonstrated in Figure 
3.2.3b. The interaction of Beclin-1 to Bcl-xL or Mcl-1 was very weak or non-
detectable, respectively. However, the interaction between Beclin-1 and 
exogenous Bcl-2 was clearly observed. 
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Figure 3.2.3 The interaction between Beclin-1 and the exogenous Bcl-2 in 
Hs578t cell. (a) Western blot analyses for the introduction of Bcl-2. Hs578t cells 
were infected with retrovirus-encoding RNA constructs for non-targeting control 
or Bcl-2 expressing vector. (b) Co-immunoprecipitation (IP) with Beclin-1. Total 
cell lysates were subjected to IP with anti-Beclin-1. Western blot analyses were 
carried out on the precipitated samples with the indicated antibodies. 
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3.2.4 Introduction of Bcl-2 inhibited radiation-induced autophagy in Hs578t 
cell. 
To examine whether the introduction of Bcl-2 contributed to the induction of 
autophagy in Hs578t cells, I determined the differences in autophagy level in 
Hs578t/control and Hs578t/Bcl-2 using acridine orange staining.  
Figure 3.2.3a demonstrates the level of Bcl-2 in Hs578t/control and Hs578t/Bcl-2 
cells. In Figure 3.2.3b acridine images indicate that radiation induced significant 
level of autophagic vesicles in Hs578t/control and lower level of the vesicles was 
detected in Hs578t/Bcl-2. Quantification of the acidic vesicles shown in Figure 
3.2.3c indicates that the percentage of acidic vesicles in Hs578t/control 
increased from 8.1% in NT condition to 40.4% at 0 hour post radiation. At 24 
hour, the amount of acidic vesicular organelles went down to 11.1%, suggesting 
that the vesicles were degraded and autophagy went to completion. In 
Hs578t/Bcl-2 cells, the percentage of acidic vesicular organelles started at 12.5% 
in NT conditions. The amount went up to 32.7% within 0 hour post radiation. 
However, at 24 hours post radiation, the amount of acidic vesicular organelles 
was 22.5%, indicating that degradation of acidic vesicular organelles in 
Hs578t/Bcl-2 was attenuated as compared to that in Hs578t/control cell. In 
addition, Western blot analyses in Figure 3.2.3d indicate that in Hs578t/control 
cell radiation could induce LC3-II accumulation as early as 0 hour post radiation. 
The level of LC3-II accumulation gradually went down together with the down-
regulation of p62 protein, suggesting that autophagy was induced and went to 
completion within 24 hours post radiation. On the other hand, in Hs578t/Bcl-2 cell 
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radiation could promote the accumulation of LC3-II. However, down-regulation of 
LC3-II and p62 were not observed within 24 hours post radiation. The data in 
Figure 3.2.3 suggest that introduction of Bcl-2 into Hs578t cell could attenuate 
the formation of autophagic vesicles and inhibited the degradation step of 
autophagy induced by radiation. 
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Figure 3.2.4 Introduction of Bcl-2 inhibited radiation-induced autophagy in 
Hs578t cell. Hs578t cells were exposed to radiation (5x2 Gy) over a period of 3 
days. (a) Bcl-2 level was analyzed by Western blot analyses comparing the 
control with Bcl-2 transfected vectors. (b) Acridine orange images were taken at 
24 hours post radiation using an inverted fluorescent microscope. 
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Figure 3.2.4 Introduction of Bcl-2 inhibited radiation-induced autophagy in 
Hs578t cell. Hs578t cells were exposed to radiation (5x2 Gy) over a period of 3 
days. (c) Acridine orange staining of acidic vesicles quantified by flow cytometry. 
Measurement of autophagy induction based on % acidic vesicular organelles 
was monitored by acridine orange staining and quantified by flow cytometry in NT 
cells and at 0 hour and 24 hours post radiation. *, p < 0.05; **, p < 0.01; ***, p < 
0.001. One-way ANOVA was followed by Bonferroni post-hoc test. Results were 
taken from three independent experiments. (d) Cell lysates were collected in NT 
cells, and at 0,6,12 and 24 hours post radiation. The lysates were subjected to 
Western blot analyses with the indicated antibodies. 
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3.2.5 Inhibition of autophagy by exogenous expression of Bcl-2 produced 
minimum changes in growth inhibition effects produced by radiation in 
Hs578t cell. 
Trypan blue exclusion assays were performed to determine the number of viable 
cells after exposure to radiation. In Figure 3.2.4a, radiation alone could mildly 
inhibit cell growth in Hs578t/control cell at 0 hour and 24 hours post radiation. 
Furthermore, stable expression of Bcl-2 in Hs578t did not alter the sensitivity of 
the cells to radiation. In Figure 3.2.4b, percentage cell viability was determined 
by normalizing the number of viable cells to the total number of viable cells and 
dead cells after 0 hour and 24 hours post radiation, indicating that minimum cell 
death was observed. Furthermore, Western blot analyses suggest that no 
cleaved-PARP expression was observed in either Hs578t/control or Hs578t/Bcl-2 
cells, indicating minimum apoptosis happened within 24 hours post radiation 
(Figure 3.2.4c). In addition, data in Figure 3.2.4d taken from clonogenic survival 
assay indicates that radiation in combination with Bcl-2 stable expression did not 
change the sensitivity of Hs578t to the growth inhibition effects on colony 
formation after exposure to radiation. In short, data in Figure 3.2.4 suggests that 
inhibition of autophagy through Bcl-2 stable expression did not alter the 
sensitivity of Hs578t to radiation. 
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Figure 3.2.5 Inhibition of autophagy by exogenous expression of Bcl-2 produced 
minimum changes in growth inhibition effects produced by radiation in Hs578t 
cell. Hs578t cells were plated with a concentration of 5x104 cells per well (six well 
tissue culture dish). The cells were exposed to radiation (5x2 Gy) over a period of 
3 days. (a) Number of viable cells was determined by Trypan Blue exclusion 
assays in NT cells, and 0 hour and 24 hours post radiation. (b) Percentage of cell 
viability was determined by Trypan blue exclusion assay. The viable cell number 
was normalized to the total number of viable cells and dead cells. 
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Figure 3.2.5 Inhibition of autophagy by exogenous expression of Bcl-2 produced 
minimum changes in growth inhibition effects produced by radiation in Hs578t 
cell. (c) Cell lysates were collected and Western blot analyses were performed 
with the indicated antibodies. (d) After exposure to radiation, the cells were 
immediately plated with a concentration of 1x104 cells per well (six well tissue 
culture dish). Number of colonies was determined by clonogenic survival assays 
over a period of 12 days. *, p < 0.05; **, p < 0.01; ***, p < 0.001. One-way 
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ANOVA was followed by Bonferroni post-hoc test. Results were taken from three 
independent experiments. 
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Section 4: Discussion 
Most breast tumor cells undergo autophagy after exposure to radiation 
(Rodemann et al., 2011). Autophagy is an important catabolic process which 
removes damaged proteins and organelles to maintain cellular homeostasis 
(Mizushima and Komatsu, 2011). Even though pro-survival autophagy is the 
main function of autophagy in response to stresses (He and Klionsky, 2009; 
Ouyyang et al., 2012), it has been suggested that autophagy can perform 
different functions in tumor cells.  
Data from this study and previous studies suggested that radiation at 5x2 Gy 
induced cytoprotective autophagy in MCF-7 cells. Inhibition of autophagy by 
silencing of Beclin-1 led to an increase in growth inhibition produced by radiation 
in MCF-7 cells (Figure 3.1.1). Interestingly, enhancement of autophagy by 
silencing of Bcl-2 did not protect the cells from radiation growth inhibition effects. 
On the other hand, enhancement of autophagy by silencing of Bcl-2 sensitized 
MCF-7 cells to radiation (Figure 3.1.4). It was shown that cell death was not the 
mode of sensitization to radiation either in Beclin-1 silencing or Bcl-2 silencing 
MCF-7 cells. Thus further experiments were needed to determine the mode of 
sensitization to radiation growth inhibition effects. 
Data from this work and previous works from the lab suggested that radiation-
induced autophagy in Hs578t played non-protective function. Inhibition of 
autophagy by silencing of Beclin-1 could not sensitize the cells to radiation 
(Figure 3.2.1). Furthermore, Hs578t is a Bcl-2 non-expressing cell line (Figure 
3.2.2). Stable expression of Bcl-2 resulted in Beclin-1/Bcl-2 interaction, which led 
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to inhibition of autophagy induced by radiation. Similarly, inhibition of autophagy 
by Bcl-2 stable expression did not alter the sensitivity of Hs578t cells to radiation 
(Figure 3.2.4).  
In conclusion, data from current study suggested that interference with 
cytoprotective autophagy (in MCF-7 cell) could result in an increase in sensitivity 
to treatment (radiation). However, alterations in non-protective autophagy (in 
Hs578t cell) did not result in either increased or decreased radiation sensitivity.  
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Section 5: Future Studies 
In MCF-7 cells, further studies are needed to determine modes of increased 
radiation sensitivity after Beclin-1 and Bcl-2 silencing. Since it was shown that 
cell death was not the mode of sensitization, it could be senescence growth 
arrest playing the role in the increase of growth inhibition after exposure to 
radiation. On the other hand, recent studies from our lab demonstrated that 
cytoprotective autophagy could be converted into cytostatic autophagy in the 
same cellular system. Cytostatic autophagy leads to cellular growth arrest. 
Therefore, it is possible that silencing of Bcl-2 in MCF-7 cell led to a conversion 
from cytoprotective into cytostatic autophagy. Therefore, future studies could be 
involved in manipulating the level of autophagy induced in Bcl-2 silencing cells. 
Also, it is important to assess whether enhancement of autophagy by different 
approach such as through rapamycin treatment could lead to similar sensitivity 
as observed in Bcl-2 silencing cells. 
In Hs578t, it looks like manipulating non-protective autophagy does not result in 
any change in radiation sensitivity. However, it is interesting that exogenous Bcl-
2 did not inhibit autophagy at the autophagic vesicle formation level. It is possible 
that Bcl-2 regulates other autophagy-related proteins downstream of Beclin-1. 
Future studies could be done to understand whether Bcl-2 is interacting or 
regulating autophagy-related proteins other than Beclin-1. 
It is also important to assess the sensitivity to treatment in other cell lines that 
induce cytoprotective autophagy and non-protective autophagy. 
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